| Product Code: ETC6130818 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Antimicrobial Resistance Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Argentina Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Argentina Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Argentina Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Argentina Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Argentina Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Argentina Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Argentina |
4.2.2 Growing awareness about the risks associated with antimicrobial resistance |
4.2.3 Government initiatives to promote responsible use of antibiotics in healthcare |
4.3 Market Restraints |
4.3.1 Lack of regulatory framework to control antibiotic use in agriculture |
4.3.2 Limited access to advanced antimicrobial therapies in certain regions of Argentina |
5 Argentina Antimicrobial Resistance Market Trends |
6 Argentina Antimicrobial Resistance Market, By Types |
6.1 Argentina Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Argentina Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Argentina Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Argentina Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Argentina Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Argentina Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Argentina Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Argentina Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Argentina Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Argentina Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Argentina Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Argentina Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Argentina Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Argentina Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Argentina Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Argentina Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Argentina Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Argentina Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Argentina Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Argentina Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Argentina Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Argentina Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Argentina Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Argentina Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Argentina Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Argentina Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Argentina Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Argentina Antimicrobial Resistance Market Export to Major Countries |
7.2 Argentina Antimicrobial Resistance Market Imports from Major Countries |
8 Argentina Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities implementing antimicrobial stewardship programs |
8.2 Number of educational campaigns on antimicrobial resistance conducted annually |
8.3 Rate of adoption of rapid diagnostic tests for antibiotic stewardship in healthcare facilities |
9 Argentina Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Argentina Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Argentina Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Argentina Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Argentina Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Argentina Antimicrobial Resistance Market - Competitive Landscape |
10.1 Argentina Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Argentina Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here